Atlas Trials

Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung Cancer

Clinical trial NCT03807102 · UNKNOWN

Trial details

NCT number
NCT03807102
Sponsor
Yongchang Zhang
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2024-01-16
Primary completion
2025-01-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.